IRA Investing Brings More and Higher-Value Investors to InSitu Biologics Reg A+ Capital RaiseBlog
RodTurner's blog When InSitu Biologics, Inc. opened its Reg A+ pre-revenue equity offering to IRA investors in 2018, company President and CEO Jim Segermark quickly realized he was attracting new investors ...